Growth in Revenue and Profit
First written in FY2026-H1. 3 of 7 entries say "Cited as achieved", first in 2026-04-30. Latest entry: 2026-09-17.
- 2026-09-17Advancedfinance.yahoo.co.jp
「In the first quarter of the fiscal year ending March 2027, sales increased both in Japan and overseas against a backdrop of growth in the infertility treatment market, with revenue reaching approximately ¥3.0 billion, up 24.0% year on year.」
Specific results were reported for the first quarter of the fiscal year ending March 2027, including sales growth in Japan and overseas and increases in revenue and profit. - 2026-07-31AdvancedEarnings
「Sales were ¥3,017 million, an increase of 24.0% year on year.」
Quarterly results showed year-on-year increases in sales, operating profit, ordinary profit and quarterly net income attributable to owners of the parent. - FY2026AdvancedAnnual report
「As a result, sales for the consolidated fiscal year were ¥10,947 million, up 6.3% year on year; operating income was ¥5,858 million, up 1.3%; ordinary income was ¥5,903 million, up 2.4%; and net income attributable to owners of the parent was ¥3,895 million, up 2.8%.」
Sales reached a record high, and sales, operating income, ordinary income and net income all increased from the previous fiscal year. - FY2026-H1First statedAnnual report
「During the current interim consolidated accounting period, our Group's sales increased 8.3% year on year to ¥5,247 million.」
Reports consolidated sales for the interim period and the year-on-year increase. Operating income was ¥2,769 million, ordinary income was ¥2,728 million, and interim net income attributable to owners of the parent was ¥1,804 million.